Stock screenerAll disclosures →
EDGAR →
PALI
Conviction 79HealthcareScan · Mon, Aug 10, 2026PALI$2.10-0.47%
ResistanceSupportVol 14Insider buyInsider sell3
Vol MA14 2.35M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price2.10
Change-0.47%
Gap-1.42%
Rel volume2.95×
Avg volume2.33M
Avg $ vol4.65M
SMA 201.99
SMA 501.94
SMA 2001.93
Price vs 50+8.31%
Price vs 200+9.08%
MA stackbullish
50/200 cross—
Supertrendup · 1.75
RSI (14)57
MACD hist0.01
MACD crossbull · 4d
Stoch %K / %D71 / 71
ADX (14)16
+DI / −DI22 / 16
RSI divergence—
MACD divergenceBullish
ATR %+5.77%
ADR %5.78%
52w high2.80
52w low0.5390
From 52w high-25.00%
Above 52w low+289.61%
New 52w highNo
SqueezeOn · 19d
Bollinger width15.11%
%B0.86
Donchian pos72.22%
Donchian high2.20
Donchian low1.84
AVWAP (52w high)1.99
vs AVWAP high+5.77%
AVWAP (52w low)1.84
vs AVWAP low+14.43%
OBV trendFlat
Chaikin MF (20)0.12
Today vs 20d2.95×
Avg vol (14d)2.35M
Avg vol (20d)2.33M
Avg $ vol (20d)4.65M
Market cap365.97M
RS 3m (vs SPY)+0.33%
RS 6m (vs SPY)+26.55%
RS line new highNo
Trend template6/8
Technical rank74.5
1 week+8.25%
1 month+7.14%
3 months+16.67%
6 months+28.05%
1 year+139.07%
YTD-16.00%
P/E-21.81
P/B3.01
P/S—
P/FCF-33.74
EPS-0.3000
Div yield—
ROE-13.78%
ROA-13.18%
Debt/Eq0.00
Current24.26
EV/EBITDA-13.34
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-16.23%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value240.88M
Revenue500K
Net income-10.57M
Gross profit—
Free cash flow-10.85M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out173.58M
Employees14
ListedWed, Apr 28, 2021
Free float164.96M
Float %99.4%
Short interest37.02M
Days to cover10.0d
Short volume54.9%
Squeeze score90 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction79 / 100
Pattern quality—
Tech rank74.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.26
Support1.72
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PALI
No recent disclosed trades by Congress in PALI. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PALI · 5 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Baltera Robert Jr. Director · Common Stock · 2026-07-09 | Buy | 25K | $49K | 2026-07-09 | 2026-07-10 |
Baltera Robert Jr. Director · Common Stock · 2026-07-08 | Buy | 20K | $40K | 2026-07-08 | 2026-07-10 |
Finley John David CEO, CFO · Common Stock · 2026-07-07 | Sell | 146.8K | $303K | 2026-07-07 | 2026-07-08 |
Baltera Robert Jr. Director · Common Stock · 2026-07-07 | Buy | 30K | $61K | 2026-07-07 | 2026-07-08 |
Finley John David CEO, CFO · Common Stock · 2026-07-07 | Exercise | 133 | $93 | 2026-07-07 | 2026-07-08 |
Finley John David CEO, CFO · Series 2 Common Stock Purchase Warrant · 2026-07-07 | Exercise | 133 | — | 2026-07-07 | 2026-07-08 |
Jones Mitchell Lawrence Chief Medical Officer · Common Stock · 2026-07-07 | Sell | 51.88K | $107K | 2026-07-07 | 2026-07-08 |
Finley John David CEO, CFO · Restricted Stock Units · 2026-07-06 | Exercise | 335.17K | — | 2026-07-06 | 2026-07-08 |
Baltera Robert Jr. Director · Common Stock · 2026-07-06 | Buy | 20K | $41K | 2026-07-06 | 2026-07-08 |
Jones Mitchell Lawrence Chief Medical Officer · Restricted Stock Units · 2026-07-06 | Exercise | 131.17K | — | 2026-07-06 | 2026-07-08 |
SEC filings
EDGAR filings in PALI · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.